NEW DELHI: Drug firm
SeQuent Scientific Ltd on Tuesday announced the launch of veterinary medicine
Halofusol in 19
European countries.
In a regulatory filing, SeQuent Scientific said it has launched Halofusol 0.5 mg/ml oral solution for calves in 19 European countries.
The product had recently received approval from European Medicines Agency (EMA) through its Spanish subsidiary Laboratorios Karizoo, S A, the company added.
It said that the new product was developed at SeQuent’s R&D centre in Barcelona, Spain and will be manufactured in Spain.
Halofusol is an oral anti-protozoal solution for the prevention and reduction of diarrhoea in new-born calves. The newly launched product is a generic version of Halocur with market size of Euro 10 million in EU, the company said.
SeQuent said it is also planning to extend the launch to other geographies.
Shares of SeQuent Scientific Ltd were trading 0.03 per cent lower at Rs 155.75 apiece on BSE.
customDimension.dimension12 = "SeQuent Scientific Ltd,European countries,Halofusol,Diarrhoea,European Medicines Agency";
customDimension.dimension13 = "12:14 PM IST";
customDimension.dimension15 = "No";
customDimension.dimension16 = "No";
(function () {
var a = window.localStorage && localStorage.getItem('et_syftCounter') || '';
a = a && JSON.parse(a) || {};
if(a.beforeSyft && customDimension) {
customDimension.dimension32 = a.beforeSyft;
}
if(a.afterSyft) {
customDimension.dimension33 = a.afterSyft;
}
})()
var contentAge = '0.00009259259259259259';
if(contentAge) {
customDimension.dimension34 = contentAge > 2 ? '>48hs':'<48hrs';
}
if(customDimension){
customDimension.dimension25 = "articleshow_main";
customDimension.dimension26 = "Industry";
customDimension.dimension27 = "Industry/Healthcare/Biotech/Pharmaceuticals/";
customDimension.dimension29 = "13352306";
customDimension.dimension48 = "79506089";
customDimension.dimension57 = _tiluuid;
}
ga('send', 'pageview', customDimension);
var newHookId ='13352306';
var newHookId2 = '13358050';
if(newHookId == '1715249553' && newHookId2 == '1052732854'){
newHookId = '1052732854'; // politicsnation
}else if(newHookId == '1715249553' && newHookId2 == '1373380680'){
newHookId = '1373380680'; // Economy
}
var subsec1_value ='13352306', subsec1_2value = '13358050';
if(subsec1_value == '1715249553' && subsec1_2value == '1052732854'){
subsec1_value = '1052732854'; // politicsnation
}else if(subsec1_value == '1715249553' && subsec1_2value == '1373380680'){
subsec1_value = '1373380680'; // Economy
}
(function (g, r, o, w, t, h, rx) {
g[t] = g[t] || function () {(g[t].q = g[t].q || []).push(arguments)
}, g[t].l = 1 * new Date();
g[t] = g[t] || {}, h = r.createElement(o), rx = r.getElementsByTagName(o)[0];
h.async = 1;h.src = w;rx.parentNode.insertBefore(h, rx)
})(window, document, 'script', 'https://static.growthrx.in/js/v2/web-sdk.js', 'grx');
grx('init', 'gf999c70d');
var grxDimension = {url: window.location.href, title : document.title, referral_url : document.referrer};
if(window.customDimension && window.objDim) {
for(key in customDimension) {
var dimId = 'd' + key.substr(9, key.length);
if(objDim[dimId] && customDimension[key]) { grxDimension[objDim[dimId]] = customDimension[key]; }
}
}
var subsStatus = 'Free User';
var jData = JSON.parse(localStorage.getItem('jStorage'));
function getCookie(n) {var ne = n + "=", ca = document.cookie.split(';');for (var i=0;i< ca.length;i++){ var c = ca[i]; while (c.charAt(0) == ' ') c = c.substring(1, c.length); if (c.indexOf(ne) == 0) return c.substring(ne.length, c.length); } return null; }
(function () {
if(ssoid = getCookie('ssoid')) {
try {
grx('userId', ssoid);
var pfuuid = getCookie('pfuuid');
if(pfuuid) { grxDimension['et_uuid'] = pfuuid}
grxDimension[objDim['d3']] = 'LOGGEDIN';
var grx_userData = jData['prime_'+getCookie('TicketId')];
grx_userData = grx_userData || {};
var grx_userPermission = grx_userData.permissions;
if(grx_userPermission.indexOf("expired_subscription") > -1) {
subsStatus = 'Expired User';
} else if (grx_userPermission.indexOf("subscribed") > -1 && grx_userPermission.indexOf("cancelled_subscription") > -1 && grx_userPermission.indexOf("can_buy_subscription") > -1) {
subsStatus = 'Paid User - In Trial';
} else if(grx_userPermission.indexOf("subscribed") > -1) {
subsStatus = 'Paid User';
} else if(grx_userPermission.indexOf("etadfree_subscribed") > -1) {
subsStatus = 'Ad Free User';
}
} catch (e) {}
} else {
grxDimension[objDim['d3']] = 'NONLOGGEDIN';
}
grxDimension[objDim['d37']] = subsStatus;
})()
grx('track', 'page_view', grxDimension);
if(geolocation && geolocation != 5 && (typeof skip == 'undefined' || typeof skip.fbevents == 'undefined')) {
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,'script',
'https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '338698809636220');
fbq('track', 'PageView');
}
var _comscore = _comscore || [];
_comscore.push({ c1: "2", c2: "6036484"});
if(geolocation && geolocation != 5) {
(function() {
var s = document.createElement('script'), el = document.getElementsByTagName("script")[0]; s.async = true;
s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
el.parentNode.insertBefore(s, el);
})();
}
if(geolocation && geolocation != 5) {
(function() {
function pingIbeat() {
window._pg_endpt=(new Date()).getTime();
var e = document.createElement('script');
e.setAttribute('language', 'javascript');
e.setAttribute('type', 'text/javascript');
e.setAttribute('src', "https://agi-static.indiatimes.com/cms-common/ibeat.min.js");
document.head.appendChild(e);
}
if(typeof window.addEventListener == 'function') {
window.addEventListener("load", pingIbeat, false);
} else {
var oldonload = window.onload;
window.onload = (typeof window.onload != 'function') ?
pingIbeat : function() { oldonload(); pingIbeat(); };
}
})();
}
}
Source link
